Patent applications published 8 December 2010
Selected patent applications from the weekly European Patents Bulletin
- Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimes
Elan Pharma International 2257159*
- Diamide inhibitors of cytochrome P450
Sequoia Pharmaceuticals 2257160*
- AHCY hydrolase inhibitors for treatment of hyper homocysteinemia
Merck Sharp & Dohme 2257161*
- Crystal forms of 2-[2’-[(cyclohexyl)methylene]hydrazino)adenosine
King Pharmaceuticals Research & Development 2257162*
- Bone paste compsn
Marfly 2257163*
- 2-aminoimidazole beta-secretase inhibitors for the treatment of Alzheimer’s disease
Merck Sharp & Dohme 2257167*
- Tetrahydrothieno pyridines
Merck Sharp & Dohme 2257169*
- Tetrahydrofuropyridones
Merck Sharp & Dohme 2257170*
- Tetrahydro-1H-pyrrolo fused pyridones
Merck Sharp & Dohme 2257171*
- Method and system for the treatment of obstructive pulmonary disease with nebulised anticholinergic administrations
Elevation Pharmaceuticals 2257172*
- Methods of treating cardiovascular disorders associated with atherosclerosis
Amcol International 2257173*
- Compsns and methods for cartilage repair
Regenerative Sciences 2257176*
- New extracts of Deschampsia antarctica desv. with antineoplastic activity
Gidekel, Manuel; Weber, Helga; Cabrera, Gustavo; Gutierrez, Ana; Osorio, Jennifer; Becera, Jose; Cafferata, Eduardo; Sunkel, Carlos; Mihovilovic, Ivan 2257177*
- Treatment of aneurysm with application of connective tissue stabilisation agent in combination with a delivery vehicle
Vatrix Medical 2257274*
- Ketorolac tromethamine compsns for treating or preventing ocular pain
Allergan 2257275*
- Solubilisation method
MediGene 2257277*
- Oral tablet compsns containing nateglinide and surfactant pH adjusting agent
Bilim Ilac Sanayi Ticaret 2257278*
- Tablets and preparation thereof
Abbott Laboratories 2257279*
- Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compsns for therapeutic use
Aparna Biosciences 2257280*
- Combination comprising a cannabinoid receptor binding compound and an opioid
Novartis 2257281*
- Fatty acid derivatives for use in the prevention and treatment of HSMI
Thia Medica 2257282*
- L-citrulline for treating endothelial dysfunction and erectile dysfunction
Androsystems 2257283*
- Combination anti-cancer agents
Spectrum Pharmaceuticals 2257285*
- Treatment for energy utilisation disease
Summit Corp 2257286*
- Method for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
Nestec 2257287*
- Valsartan solid oral dosage forms and methods of making such formulations
Novartis 2257288*
- Pharmaceutical compsn for use in the treatment of prevention of osteoarticular diseases
Bone Therapeutics 2257289*
- Kit, compsn, product or medicament for treating cognitive impairment
Zenyaku Kogyo Kabushikikaisha 2257290*
- pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
Xenon Pharmaceuticals; Novartis 2257291*
- Zn/trimehoprim combination therapy
El-Habbal, Magdi 2257292*
- Combination therapy with C-met and EGFR antagonists
Genentech 2257293*
- Treatment of herpes virus related diseases
Exley, Ray 2257294*
- Photodynamic therapy process and photosensitiser compsns
Ondine International 2257295*
- Polyaromatic sodium channel blockers
Parion Sciences 2257296*
- Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
Mimetica 2257297*
- Genetic polymorphisms associated with stroke, methods of detection and uses thereof
Celera Corp 2257298*
- Modulation of SPRX2-mediated angiogenesis
Research Development Foundation 2257299*
- Allogeneic cancel cell-based immunotherapy
University of Miami 2257301*
- Extracts of Scleorcarya birrea
Management and Holdings - Ardom 2257302*
- Uses of modulated ELR-CXC chemokine G31P
University of Saskatechwan 2257303*